Skip to main content Accessibility help
×
Home
  • Online publication date: March 2015

Chapter 3 - Pathology of selected infectious diseases

References

1. Procop GW, Wilson M. Infectious disease pathology. Clin Infect Dis 2001; 32(11): 1589–1601.
2. Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am 2003; 17(1): 113–134, viii.
3. Woods GL, Walker DH. Detection of infection or infectious agents by use of cytologic and histologic stains. Clin Microbiol Rev 1996; 9: 382.
4. Prophet EB, Mills B, Arrington JB, et al., eds. Laboratory Methods in Histotechnology. Washington: American Registry of Pathology; 1992.
5. Brown RC, Hopps HC. Staining of bacteria in tissue sections: a reliable Gram stain method. Am J Clin Pathol 1973; 60: 234.
6. Wear DJ, Margileth AM, Hadfield TL, et al. Cat scratch disease: a bacterial infection. Science 1983; 221: 1403.
7. Chandler FW, Hicklin MD, Blackmon JA. Demonstration of the agent of Legionnaires’ disease in tissue. N Engl J Med 1977; 297: 1218.
8. Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 2: 1273.
9. Woods GL, Meyers WM. Mycobacterial diseases. In: Damjanov I, Linder J, eds. Anderson’s Pathology, 10th edn. St. Louis: CV Mosby; 1996: 843–865.
10. Robboy SJ, Vickery AL Jr. Tinctorial and morphologic properties distinguishing actinomycosis and nocardiosis. N Engl J Med 1970; 282: 593.
11. Lowe RN, Azimi PH, McQuitty J. Acid-fast Actinomyces in a child with pulmonary actinomycosis. J Clin Microbiol 1980; 12: 124.
12. Monheit JE, Brown G, Kott MM, et al. Calcofluor white detection of fungi in cytopathology. Am J Clin Pathol 1986; 85: 222.
13. Monheit JE, Cowan DF, Moore DG. Rapid detection of fungi in tissues using calcofluor white and fluorescence microscopy. Arch Pathol Lab Med 1984; 108: 616.
14. Wood C, Russel-Bell B. Characterization of pigmented fungi by melanin staining. Am J Dermatopathol 1983; 5: 77.
15. Baselski VS, Robison MK, Pifer LW, et al. Rapid detection of Pneumocystis carinii in bronchoalveolar lavage samples by using Cellufluor staining. J Clin Microbiol 1990; 28: 393.
16. Gosey LL, Howard RM, Witebsky FG, et al. Advantages of a modified toluidine blue O stain and bronchoalveolar lavage for the diagnosis of Pneumocystis carinii pneumonia. J Clin Microbiol 1985; 22: 803.
17. Rosen PP, Martini N, Armstrong D. Pneumocystis carinii pneumonia. Diagnosis by lung biopsy. Am J Med 1975; 58: 794.
18. Kim YK, Parulekar S, Yu PK, et al. Evaluation of calcofluor white stain for detection of Pneumocystis carinii. Diagn Microbiol Infect Dis 1990; 13: 307.
19. Elston HR. Synthetic controls for microbiological stains in histopathology. Lab Med 1986; 17: 750.
20. Tseng CH, Tseng C. Laboratory method for producing tissue controls for fungal stains. Lab Med 1991; 22: 637.
21. Jung WK. In vitro positive controls for histochemical stains of bacteria and fungi. Am J Clin Pathol 1985; 84: 342.
22. Eyzaguirre E, Haque AK. Application of immunohistochemistry to infections. Arch Pathol Lab Med 2008; 132: 424–431.
23. Eyzaguirre EJ, Walker DW, Zaki SR. Immunohistology of infectious diseases. In Dabbs DJ, ed. Diagnostic Immunohistochemistry, 2nd edn. New York: Elsevier; 2006: 43–64.
24. Marcio L, Angelucci D, Grossi L, et al. Anti-Helicobacter pylori-specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimens from patients treated with triple therapy. Am J Gastroenterol 1998; 93: 223–226.
25. Fukuzawa M, Inaba H, Hayama M, et al. Improved detection of medically-important fungi by immunoperoxidase staining with polyclonal antibodies. Virchows Arch 1995; 427: 407–414.
26. Neinstein LS, Rabinovitz S. Detection of Chlamydia trachomatis. A study of the direct immunofluorescence technique and a review of diagnostic limitations. J Adolesc Health Care 1989; 10(1): 10–15.
27. Mann JL. Autofluorescence of fungi: an aid to detection in tissue sections. Am J Clin Pathol 1983; 79(5): 587–590.
28. Hettlich C, Kupper TH, Wehle K, et al. Aspergillus in the Papanicolaou stain: morphology, fluorescence and diagnostic feasibility. Cytopathology 1998; 9(6): 381–388.
29. Schroder S, Hain M, Sterflinger K. Colorimetric in situ hybridization (CISH) with digoxigenin-labeled oligonucleotide probes in autofluorescent hyphomycetes. Int Micrbiol 2000; 3(3): 183–186.
30. Horsburgh CR Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 1332.
31. Klatt EC, Jensen DF, Meyer PR. Pathology of Mycobacterium aviumintracellulare infection in acquired immunodeficiency syndrome. Hum Pathol 1987; 18: 709.
32. Gillin JS, Urmacher C, West R, et al. Disseminated Mycobacterium aviumintracellulare infection in acquired immunodeficiency syndrome mimicking Whipple’s disease. Gastroenterology 1983; 85: 1187.
33. Umlas J, Federman M, Crawford C, et al. Spindle cell pseudotumor due to Mycobacterium aviumintracellulare in patients with acquired immunodeficiency syndrome (AIDS). Positive staining of mycobacteria for cytoskeleton filaments. Am J Surg Pathol 1991; 15: 1181.
34. Scott MA, Graham B, Verrall R, et al. Rhodococcus equi. An increasingly recognized opportunistic pathogen: report of 12 cases and review of 65 cases in the literature. Am J Clin Pathol 1995; 103(5): 649–655.
35. Emmons W, Reichwein B, Winslow DL. Rhodococcus equi infection in the patient with AIDS: literature review and report of an unusual case. Rev Infect Dis 1991; 13: 91.
36. van Etta LL, Filice GA, Ferguson RM, et al. Corynebacterium equi: a review of 12 cases of human infection. Rev Infect Dis 1983; 5: 1012.
37. Lasky JA, Pulkingham N, Powers MA, et al. Rhodococcus equi causing human pulmonary infection: review of 29 cases. South Med J 1991; 84: 1217.
38. Winn WC Jr, Myerowitz RL. The pathology of the Legionella pneumonias. A review of 74 cases and the literature. Hum Pathol 1981; 12: 401.
39. Simpson GL, Stinson EB, Egger MJ, et al. Nocardial infections in the immunocompromised host: a detailed study in a defined population. Rev Infect Dis 1981; 3: 492.
40. Javaly K, Horowitz HW, Wormser GP. Nocardiosis in patients with human immunodeficiency virus infection. Report of 2 cases and review of the literature. Medicine 1992; 71: 128.
41. Larone DH. Medically Important Fungi – A Guide to Identification, 3rd edn. Washington, DC: ASM Press; 1995.
42. de Hoog GS, Guarro J, Gene J, et al. Atlas of Clinical Fungi, 2nd edn. The Netherlands: Centraalbureau voor Schimmerlculture; 2000.
43. Chandler FW, Watts JC. Pathologic Diagnosis of Fungal Infections. Chicago: ASCP Press; 1987.
44. Strano AJ. Light microscopy of selected viral diseases (morphology of viral inclusion bodies). Pathol Ann 1976; 11: 53.
45. Cheville NF. Cytopathology in Viral Diseases. Basel: S Karger; 1975.
46. Connor DH, Chandler FW, Schwartz DA, et al. Pathology of Infectious Diseases. Stamford, CT: Appleton & Lange; 1997.
47. Stevens DL, Musher DM, Watson DA, et al. Spontaneous, nontraumatic gangrene due to Clostridium septicum. Rev Infect Dis 1990; 12: 286.
48. Kaiser CW, Milgrom ML, Lynch JA. Distant nontraumatic clostridial myonecrosis and malignancy. Cancer 1986; 57: 885.
49. Narula A, Khatib R. Characteristic manifestations of clostridium induced spontaneous gangrenous myositis. Scand J Infect Dis 1985; 17: 291.
50. Brown JR. Human actinomycosis: a study of 181 subjects. Hum Pathol 1973; 4: 319.
51. Sudhakar SS, Ross JJ. Short-term treatment of actinomycosis: two cases and a review. Clin Infect Dis. 2004; 38(3): 444–447.
52. Schmidt WA. IUDs, inflammation, and infection: assessment after two decades of IUD use. Hum Pathol 1982; 13: 878.
53. Bhagavan BS, Gupta PK. Genital actinomycosis and intrauterine contraceptive devices. Cytopathologic diagnosis and clinical significance. Hum Pathol 1978; 9: 567.
54. Burkman RT, Schlesselman S, McCaffrey L, et al. The relationship of genital tract Actinomyces and the development of pelvic inflammatory disease. Am J Obstet Gynecol 1982; 143: 585.
55. Wilson DJ. Botryomycosis. Am J Pathol 1959; 35: 153.
56. Greenblatt M, Heredia R, Rubenstein L, et al. Bacterial pseudomycosis (“botryomycosis”). Am J Clin Pathol 1964; 41: 188.
57. de Vries HJ, van Noesel CJ, Hoekzema R, et al. Botryomycosis in an HIV-positive subject. J Eur Acad Dermatol Venereol 2003; 17(1): 87–90.
58. Qureshi F, Jacques SM, Reyes MP. Placental histopathology in syphilis. Hum Pathol 1993; 24: 779.
59. Murray FE, O’Loughlin S, Dervan P, et al. Granulomatous hepatitis in secondary syphilis. Ir J Med Sci 1990; 159: 53.
60. Wu SJ, Nguyen EQ, Nielsen TA, et al. Nodular tertiary syphilis mimicking granuloma annulare. J Am Acad Dermatol 2000; 42(2 Pt 2): 378–380.
61. Ito F, Hunter EF, George RW, et al. Specific immunofluorescence staining of Treponema pallidum in smears and tissues. J Clin Microbiol 1991; 29: 444.
62. Saral R. Candida and Aspergillus infections in immunocompromised patients: an overview. Rev Infect Dis 1991; 13: 487.
63. Wingard JR, Merz WG, Saral R. Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med 1979; 91: 539.
64. Weems JJ Jr. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 1992; 14: 756.
65. Goldman M, Pottage JC Jr, Weaver DC. Candida krusei fungemia. Report of 4 cases and review of the literature. Medicine (Baltimore) 1993; 72: 143.
66. Johnson TL, Barnett JL, Appelman HD, et al. Candida hepatitis. Histopathologic diagnosis. Am J Surg Pathol 1988; 12: 716.
67. Ostrosky-Zeichner L, Rex JH, Bennett J, et al. Deeply invasive candidiasis. Infect Dis Clin North Am 2002; 16(4): 821–835.
68. Haron E, Vartivarian S, Anaissie E, et al. Primary Candida pneumonia. Experience at a large cancer center and review of the literature. Medicine (Baltimore) 1993; 72: 137.
69. Parker JC Jr, McCloskey JJ, Lee RS. Human cerebral candidosis – a postmortem evaluation of 19 patients. Hum Pathol 1981; 12: 23.
70. Cha R, Sobel JD. Fluconazole for the treatment of candidiasis: 15 years experience. Expert Rev Anti Infect Ther 2004; 2(3): 357–366.
71. Lurie HI. Histopathology of sporotrichosis. Notes on the nature of the asteroid body. Arch Pathol 1963; 75: 421.
72. Ro JY, Luna MA, Mackay B, et al. Yellow–brown (Hamazaki–Wesenberg) bodies mimicking fungal yeasts. Arch Pathol Lab Med 1987; 111(6): 555–559.
73. Takemura T, Eishi Y, Matsui Y. An autopsy case of sarcoidosis followed up for 27 years, with special reference to pulmonary fibrosis. Acta Pathol Jpn 1988; 38(7): 909–920.
74. Grotte M, Younger B. Sporotrichosis associated with sphagnum moss exposure. Arch Pathol Lab Med 1981; 105: 50.
75. Coles FB, Schuchat A, Hibbs JR, et al. A multistate outbreak of sporotrichosis associated with sphagnum moss. Am J Epidemiol 1992; 136: 475.
76. Sanders E. Cutaneous sporotrichosis. Beer, bricks, and bumps. Arch Intern Med 1971; 127: 482.
77. Morris-Jones R. Sporotrichosis. Clin Exp Dermatol 2002; 27(6): 427–431.
78. England DM, Hochholzer L. Primary pulmonary sporotrichosis. Report of eight cases with clinicopathologic review. Am J Surg Pathol 1985; 9: 193.
79. De Hoog GS, Queiroz-Telles F, Haase G, et al. Black fungi: clinical and pathogenic approaches. Med Mycol 2000; 38(Suppl 1): 243–250.
80. Bonifaz A, Paredes-Solis V, Saul A. Treating chromoblastomycosis with systemic antifungals. Expert Opin Pharmacother 2004; 5(2): 247–254.
81. Kantrow SM, Boyd AS. Protothecosis. Dermatol Clin 2003; 21(2): 249–255.
82. Nosanchuk JS, Greenberg RD. Protothecosis of the olecranon bursa caused by achloric algae. Am J Clin Pathol 1973; 59: 567.
83. Chandler FW, Kaplan W, Callaway CS. Differentiation between Prototheca and morphologically similar green algae in tissue. Arch Pathol Lab Med 1978; 102: 353.
84. Holcomb HS III, Behrens F, Winn WC Jr, et al. Prototheca wickerhamii – an alga infecting the hand. J Hand Surg [Am] 1981; 6: 595.
85. Wirth FA, Passalacqua JA, Kao G. Disseminated cutaneous protothecosis in an immunocompromised host: a case report and literature review. Cutis 1999; 63(3): 185–188.
86. Brandt ME, Warnock DW. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother Suppl 2003; 2: 36–47.
87. Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis 2004; 38(2): 206–216.
88. Clancy CJ, Wingard JR, Hong Nguyen M. Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents. Med Mycol 2000; 38(2): 169–175.
89. McGinnis MR. Mycetoma. Dermatol Clin 1996; 14(1): 97–104.
90. Fahal AH. Mycetoma: a thorn in the flesh. Trans R Soc Trop Med Hyg 2004; 98(1): 3–11.
91. Venugopal PV, Venugopal TV. Actinomadura madurae mycetomas. Australas J Dermatol 1990; 31(1): 33–36.
92. Boiron P, Locci R, Goodfellow M, et al. Nocardia, nocardiosis and mycetoma. Med Mycol 1998; 36(Suppl 1): 26–37.
93. Brumback BG, Farthing PG, Castellino SN. Simultaneous detection of and differentiation between herpes simplex and varicella-zoster viruses with two fluorescent probes in the same test system. J Clin Microbiol 1993; 31: 3260.
94. Nahmias AJ, Whitley RJ, Visintine AN, et al. Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis 1982; 145: 829.
95. Pollara G, Katz DR, Chain BM. The host response to herpes simplex virus infection. Curr Opin Infect Dis 2004; 17(3): 199–203.
96. Drew WL, Buhles W, Ehrlich KS. Herpesvirus infections (CMV, HSV, VZV). Infect Dis Clin North Am 1986; 2: 495–505.
97. DeMay RM. The Art & Science of Cytopathology. Chicago: ASCP Press; 1995.
98. Gurevich I. Varicella-zoster and herpes simplex virus infections. Heart Lung 1992; 21(1): 85–91.
99. Kazory A, Ducloux D. Renal transplantation and polyomavirus infection: recent clinical facts and controversies. Transpl Infect Dis 2003; 5(2): 65–71.
100. Aksamit AJ Jr. Progressive multifocal leukoencephalopathy: a review of the pathology and pathogenesis. Microsc Res Tech 1995; 32(4): 302–311.
101. Bultmann BD, Klingel K, Sotlar K, et al. Parvovirus B19: a pathogen responsible for more than hematologic disorders Virchows Arch 442(1): 8–17. Epub 2002 Nov 14, 2003.
102. Bikowski JB Jr. Molluscum contagiosum: the need for physician intervention and new treatment options. Cutis 2004; 73(3): 202–206.
103. Melby PC, Kreutzer RD, McMahon-Pratt D, et al. Cutaneous leishmaniasis: review of 59 cases seen at the National Institutes of Health. Clin Infect Dis 1992; 15: 924.
104. Magill AJ, Grögl M, Gasser RA Jr, et al. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993; 328: 1383.
105. Fernandez-Guerrero ML, Aguado JM, Buzon L, et al. Visceral leishmaniasis in immunocompromised hosts. Am J Med 1987; 83: 1098.
106. Berenguer J, Moreno S, Cercenado E, et al. Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med 1989; 111: 129.
107. Olivier M, Badaro R, Medrano FJ, et al. The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms. Ann Trop Med Parasitol 2003; 97(Suppl 1): 79–98.
108. Kayes SG. Human toxocariasis and the visceral larva migrans syndrome: correlative immunopathology. Chem Immunol 1997; 66: 99–124.
109. Bennhoff DF. Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases. Laryngoscope 1984; 94: 1198–1217.
110. Cunningham ET, Koehler JE. Ocular bartonellosis. Am J Ophthalmol 2000; 130(3): 340–349.
111. Carithers HA. Cat scratch disease. A overview based on a study of 1200 patients. Am J Dis Child 1985; 139: 1124–1133.
112. Attia OM. Rhinoscleroma and malignancy: two cases of rhinoscleroma associated with carcinoma. J Laryngol Otol 1958; 72: 412–415.
113. Lenis A, Ruff T, Diaz JA, et al. Rhinoscleroma. South Med J 1988; 81(12): 1580–1582.
114. Juster-Reicher A, Moligner BM, Levi G, et al. Neonatal noma. Am J Perinatol 1993; 10: 409–411.
115. Linder R. Rhodococcus equi and Arcanobacterium haemolyticum: two ‘coryneform’ bacteria increasingly recognized as agents of human infection. Emerg Infect Dis 1997; 3(2): 145–153.
116. Hanson JM, Spector G, El-Mofty SK. Laryngeal blastomycosis: a commonly missed diagnosis. Report of two cases and review of the literature. Ann Otol Rhinol Laryngol 2000; 109(3): 281–286.
117. Sant’Anna GD, Mauri M, Arrarte JL, et al. Laryngeal manifestations of paracoccidioidomycosis (South American blastomycosis). Arch Otolaryngol Head Neck Surg 1999; 125(12): 1375–1378.
118. Wolf J, Blumberg HM, Leonard MK. Laryngeal histoplasmosis. Am J Med Sci 2004; 327(3): 160–162.
119. Boyle JO, Coulthard SW, Mandel RM. Laryngeal involvement in disseminated coccidioidomycosis. Arch Otolaryngol Head Neck Surg 1991; 117(4): 433–438.
120. Nadrous HF, Ryu JH, Lewis JE, et al. Cryptococcal laryngitis: case report and review of the literature. Ann Otol Rhinol Laryngol 2004; 113(2): 121–123.
121. Madana J, Yolmo D, Gopalakrishnan S, Saxena SK. Rhinosporidiosis of the upper airways and trachea. J Laryngol Otol 2010; 124: 1139–1141.
122. Wheeler MS, McGinnis MR, Schell WA, et al. Fusarium infection in burned patients. Am J Clin Pathol 1981; 75: 304.
123. Louie T, el Baba F, Shulman M, et al. Endogenous endophthalmitis due to Fusarium: case report and review. Clin Infect Dis 1984; 18: 585.
124. Gamis AS, Gudnason T, Giebink GS, et al. Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev Infect Dis 1991; 13: 1077.
125. Reimer LG. Q fever. Clin Microbiol Rev 1993; 6: 193.
126. Spelman DW. Q fever. A study of 111 consecutive cases. Med J Aust 1982; 1: 547.
127. Hall CJ, Richmond SJ, Caul EO, et al. Laboratory outbreak of Q fever acquired from sheep. Lancet 1982; 1: 1004.
128. Srigley JR, Vellend H, Palmer N, et al. Q-fever. The liver and bone marrow pathology. Am J Surg Pathol 1985; 9: 752.
129. Pellegrin M, Delsol G, Auvergnant JC, et al. Granulomatous hepatitis in Q fever. Hum Pathol 1980; 11: 51.
130. Lobdell DH. ‘Ring’ granulomas in cytomegalovirus hepatitis. Arch Pathol Lab Med 1987; 111: 881.
131. Ruel M, Sevestre H, Henry-Biabaud E, et al. Fibrin ring granulomas in hepatitis A. Dig Dis Sci 1992; 37: 1915.
132. Barnes PF, Cave MD. Molecular epidemiology of tuberculosis. N Engl J Med 2003; 349(12): 1149–1156.
133. Goodwin RA, Des Prez RM. Pathogenesis and clinical spectrum of histoplasmosis. South Med J 1973; 66: 13.
134. Johnson PC, Khardori N, Najjar AF, et al. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85: 152.
135. Reddy P, Gorelick DF, Brasher CA, et al. Progressive disseminated histoplasmosis as seen in adults. Am J Med 1970; 48: 629.
136. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990; 69: 361.
137. Studdard J, Sneed WF, Taylor MR Jr, et al. Cutaneous histoplasmosis. Am Rev Respir Dis 1976; 113: 689.
138. Goodwin RA, Owens FT, Snell JD, et al. Chronic pulmonary histoplasmosis. Medicine (Baltimore) 1995; 55: 413.
139. Loyd JE, Tillman BF, Atkinson JB, et al. Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore) 1988; 67: 295.
140. Goodwin RA, Nickell JA, Des Prez RM. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore) 1972; 51: 227.
141. Sarosi GA, Hammerman KJ, Tosh FE, et al. Clinical features of acute pulmonary blastomycosis. N Engl J Med 1974; 290: 540.
142. Witorsch P, Utz JP. North American blastomycosis: a study of 40 patients. Medicine (Baltimore) 1968; 47: 169.
143. Pappas PG, Threlkeld MG, Bedsole GD, et al. Blastomycosis in immunocompromised patients. Medicine (Baltimore) 1993; 72: 311.
144. Atkinson JB, McCurley TL. Pulmonary blastomycosis: filamentous forms in an immunocompromised patient with fulminating respiratory failure. Hum Pathol 1983; 14: 186.
145. Case Records of the Massachusetts General Hospital. Case 49–1988: Histoplasma capsulatum or Blastomyces dermatitidis? N Engl J Med 1989; 320: 1699.
146. Lemos LB, Baliga M, Guo M. Blastomycosis: the great pretender can also be an opportunist. Initial clinical diagnosis and underlying diseases in 123 patients. Ann Diagn Pathol 2002; 6(3): 194–203.
147. Freed ER, Duma RJ, Shadomy HJ, et al. Meningoencephalitis due to hyphae-forming Cryptococcus neoformans. Am J Clin Pathol 1971; 55: 30.
148. Salyer WR, Salyer DC, Baker RD. Primary complex of Cryptococcus and pulmonary lymph nodes. J Infect Dis 1974; 130: 74.
149. Baker RD. The primary pulmonary lymph node complex of cryptococcosis. Am J Clin Pathol 1976; 65: 83.
150. McDonnell JM, Hutchins GM. Pulmonary cryptococcosis. Hum Pathol 1985; 16: 121.
151. Anderson DJ, Schmidt C, Goodman J, et al. Cryptococcal disease presenting as cellulitis. Clin Infect Dis 1992; 14: 666.
152. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321: 794.
153. Farmer SG, Komorowski RA. Histologic response to capsule-deficient Cryptococcus neoformans. Arch Pathol 1973; 96: 383.
154. Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin North Am 2002; 16(4): 837–874; v–vi.
155. Ro JY, Lee SS, Ayala AG. Advantage of Fontana–Masson stain in capsule-deficient cryptococcal infection. Arch Pathol Lab Med 1987; 111: 53.
156. Lazcano O, Speights VO Jr, Bilbao J, et al. Combined Fontana–Masson–Mucin staining of Cryptococcus neoformans. Arch Pathol Lab Med 1991; 115: 1145.
157. Stevens DA. Coccidioidomycosis. N Engl J Med 1995; 332: 1077.
158. Pappagianis D. Marked increase in cases of coccidioidomycosis in California: 1991, 1992, and 1993. Clin Infect Dis 1994; 19(Suppl 1): S14.
159. Galgani JN, Ampel NM. Coccidioidomycosis in human immunodeficiency virus-infected patients. J Infect Dis 1990; 162: 1165.
160. Fish DG, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore) 1990; 69: 384.
161. Vincent T, Galgiani JN, Huppert M, et al. The natural history of coccidioidal meningitis: VA-Armed Forces cooperative studies, 1955–1958. Clin Infect Dis 1993; 16: 247.
162. Macher AM, Shelhamer J, MacLowry J, et al. Pneumocystis carinii identified by Gram stain of lung imprints. Ann Intern Med 1983; 99: 484.
163. Ghali VS, Garcia RL, Skolom J. Fluorescence of Pneumocystis carinii in Papanicolaou smears. Hum Pathol 1984; 15: 907.
164. Wolfson JS, Waldron MA, Sierra LS. Blinded comparison of a direct immunofluorescent monoclonal antibody staining method and a Giemsa staining method for identification of Pneumocystis carinii in induced sputum and bronchoalveolar lavage specimens of patients infected with human immunodeficiency virus. J Clin Microbiol 1990; 28: 2136.
165. Midgley J, Parsons PA, Shanson DC, et al. Monoclonal immunofluorescence compared with silver stain for investigating Pneumocystis carinii pneumonia. J Clin Pathol 1991; 44: 75.
166. Kovacs JA, Gill V, Swan JC, et al. Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia. Lancet 1986; 2: 1.
167. Singer C, Armstrong D, Rosen PP, et al. Pneumocystis carinii pneumonia: a cluster of eleven cases. Ann Intern Med 1975; 82: 772.
168. Pifer LL, Hughes WT, Stagno S, et al. Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics 1978; 61: 35.
169. Walzer PD, Perl DP, Krogstad DJ, et al. Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med 1974; 80: 83.
170. Gottlieb MS, Schroff R, Schanker HM, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. Evidence for a new acquired cellular immunodeficiency. N Engl J Med 1981; 305: 1425.
171. Masur H, Michelis MA, Greene JB, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia. Initial manifestation of cellular immune dysfunction. N Engl J Med 1981; 305: 1431.
172. Wang NS, Huang SN, Thurlbeck WM. Combined Pneumocystis carinii and cytomegalovirus infection. Arch Pathol 1970; 90: 529.
173. Schneider MME, Hoepelman AIM, Schattenkerk JKME, et al. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 1992; 327: 1836.
174. Telzak EE, Cote RJ, Gold JW, et al. Extrapulmonary Pneumocystis carinii infections. Rev Infect Dis 1990; 12: 380.
175. Lee MM, Schinella RA. Pulmonary calcification caused by Pneumocystis carinii pneumonia. A clinicopathological study of 13 cases in acquired immune deficiency syndrome patients. Am J Surg Pathol 1991; 15: 376.
176. Askin FB, Katzenstein AL. Pneumocystis infection masquerading as diffuse alveolar damage: a potential source of diagnostic error. Chest 1981; 79: 420.
177. Cupples JB, Blackie SP, Road JD. Granulomatous Pneumocystis carinii pneumonia mimicking tuberculosis. Arch Pathol Lab Med 1989; 113: 1281.
178. Travis WD, Pittaluga S, Lipschik GY, et al. Atypical pathologic manifestations of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Review of 123 lung biopsies from 76 patients with emphasis on cysts, vascular invasion, vasculitis, and granulomas. Am J Surg Pathol 1990; 14: 615.
179. Golden JA, Hollander H, Stulbarg MS, et al. Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia. A prospective study among patients with acquired immunodeficiency syndrome. Chest 1986; 90: 18.
180. Johnson WW, Elson CE. Respiratory tract. In: Bibbo M, ed. Comprehensive Cytopathology. Philadelphia: WB Saunders; 1991: 340–352.
181. Jones PD, See J. Penicillium marneffei infection in patients infected with human immunodeficiency virus: late presentation in an area of nonendemicity. Clin Infect Dis 1992; 15: 744.
182. Deng ZL, Connor DH. Progressive disseminated penicilliosis caused by Penicillium marneffei. Report of eight cases and differentiation of the causative organism from Histoplasma capsulatum. Am J Clin Pathol 1985; 84: 323.
183. Cooper CR Jr, Haycocks NG. Penicillium marneffei: an insurgent species among the penicillia. J Eukaryot Microbiol 2000; 47(1): 24–28.
184. Butler JC, Heller R, Wright PF. Histoplasmosis during childhood. South Med J 1994; 87: 476.
185. Bosken CH, Myers JL, Greenberger PA, et al. Pathologic features of allergic bronchopulmonary aspergillosis. Am J Surg Pathol 1988; 12: 216.
186. Katzenstein AL, Liebow AA, Friedman PJ. Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi. Am Rev Respir Dis 1975; 111: 497.
187. Katzenstein AL, Sale SR, Greenberger PA. Pathologic findings in allergic aspergillus sinusitis. A newly recognized form of sinusitis. Am J Surg Pathol 1983; 7: 439.
188. Myers JL, Katzenstein AL. Granulomatous infection mimicking bronchocentric granulomatosis. Am J Surg Pathol 1986; 10: 317.
189. Engblom E, Ekfors TO, Meurman OH, et al. Fatal influenza A myocarditis with isolation of virus from the myocardium. Acta Med Scand 1983; 213: 75.
190. Englund JA, Sullivan CJ, Jordan MC, et al. Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med 1988; 109: 203.
191. Takimoto CH, Cram DL, Root RK. Respiratory syncytial virus infections on an adult medical ward. Arch Intern Med 1991; 151: 706.
192. Duke T, Mgone CS. Measles: not just another viral exanthem. Lancet 2003; 361(9359): 763–773.
193. Nolte KB, Feddersen RM, Foucar K, et al. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol 1995; 26: 110.
194. Zaki SR, Khan AS, Goodman RA, et al. Retrospective diagnosis of hantavirus pulmonary syndrome, 1978–1993: implications for emerging infectious diseases. Arch Pathol Lab Med 1996; 120: 134.
195. Sampathkumar P, Temesgen Z, Smith TF, et al. SARS: epidemiology, clinical presentation, management, and infection control measures. Mayo Clin Proc 2003; 78(7): 882–890.
196. Yu IT, Sung JJ. The epidemiology of the outbreak of severe acute respiratory syndrome (SARS) in Hong-Kong – what we do know and what we don’t. Epidemiol Infect 2004; 132(5): 781–786.
197. Cheung OY, Chan JW, Ng CK, et al. The spectrum of pathological changes in severe acute respiratory syndrome (SARS). Histopathol 2004; 45(2): 119–124.
198. Mizrachi HH, Lieberman PH, Tolui SS, et al. Pulmonary dirofilariasis: mimicry of well-differentiated squamous carcinoma. Hum Pathol 1989; 20: 818.
199. Ro JY, Tsakalakis PJ, White VA, et al. Pulmonary dirofilariasis: the great imitator of primary or metastatic lung tumor. A clinicopathologic analysis of seven cases and a review of the literature. Hum Pathol 1989; 20: 69.
200. Gutierrez Y. Diagnostic features of zoonotic filariae in tissue sections. Hum Pathol 1984; 15: 514.
201. Metre MS, Jayaram G. Acid-fast bacilli in aspiration smears from tuberculous lymph nodes: an analysis of 255 cases. Acta Cytol 1987; 31: 17.
202. Maygarden SJ, Flanders EL. Mycobacteria can be seen as ‘negative images’ in cytology smears from patients with acquired immunodeficiency syndrome. Mod Pathol 1989; 2: 239.
203. Margileth AM, Hayden GF. Cat scratch disease. N Engl J Med 1993; 329: 53.
204. Schwartzman WA. Infections due to Rochalimaea: the expanding clinical spectrum. Clin Infect Dis 1992; 15: 893.
205. Margileth AM, Wear DJ, English CK. Systemic cat scratch disease: report of 23 patients with prolonged or recurrent severe bacterial infection. J Infect Dis 1987; 155: 390.
206. Miller Catchpole R, Variakojis D, Vardiman JW, et al. Cat scratch disease. Identification of bacteria in seven cases of lymphadenitis. Am J Surg Pathol 1986; 10: 276.
207. Lamps LW, Gray GF, Scott MA. Hepatic cat scratch disease – the histologic spectrum of changes in confirmed Bartonella henselae infection. Am J Surg Pathol 1996; 20: 1253–1259.
208. Scott MA, McCurley TL, Vnencak-Jones CL, et al. Cat scratch disease – detection of Bartonella henselae DNA in archival biopsies from patients with clinically, serologically and histologically defined disease. Am J Pathol 1996; 149(6): 2161–2167.
209. Cohen MB, Miller TR, Bottles K. Classics in cytology; note on fine needle aspiration of the lymphatic glands in sleeping sickness. Acta Cytol 1986; 30: 451.
210. Stastny JF, Wakely PE Jr, Frable WJ. Cytologic features of necrotizing granulomatous inflammation consistent with cat-scratch disease. Diagn Cytopathol 1996; 15: 108.
211. Pullen RL, Stuart BM. Tularemia analysis of 225 cases. JAMA 1945; 129: 495.
212. Stuart BM, Pullen RL. Tularemic pneumonia. Review of American literature and report of 15 additional cases. Am J Med Sci 1945; 210: 223.
213. Mille RP, Bates JH. Pleuropulmonary tularemia. A review of 29 patients. Am Rev Respir Dis 1969; 99: 31.
214. Brooks GF, Buchanan TM. Tularemia in the United States – epidemiologic aspects in the 1960s and follow-up of the outbreak of tularemia in Vermont. J Infect Dis 1970; 121: 357.
215. Evans ME, Gregory DW, Schaffner W, et al. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 1985; 64: 251.
216. Lamps LW, Havens JM, Sjostedt A, et al. Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America. Mod Pathol 2004; 17(5): 489–495.
217. Reed W, Palmer D, Williams RC Jr, et al. Plague in the southwestern United States – a review of recent experience. Medicine (Baltimore) 1970; 19: 465.
218. Reilly CG, Kates ED. The clinical spectrum of plague in Vietnam. Arch Intern Med 1970; 126: 990.
219. Sternby NH. Morphologic findings in appendix in human Yersinia enterocolitica infection. Contrib Microbiol Immunol 1973; 2: 141.
220. Gleason TH, Patterson SD. The pathology of Yersinia enterocolitica ileocolitis. Am J Surg Pathol 1982; 6: 347.
221. Finlayson NB, Fagundes B. Pasteurella pseudotuberculosis infection: three cases in the United States. Am J Clin Pathol 1971; 55: 24.
222. Hubbert WT, Peteny CW, Glasgow LA. Yersinia pseudotuberculosis infection in the United States: septicemia, appendicitis, and mesenteric lymphadenitis. Am J Trop Med Hyg 1971; 20: 679.
223. Lamps LW, Madhusudhan KT, Greenson JK, et al. The role of Yersinia enterocolitica and Yersinia pseudotuberculosis in granulomatous appendicitis: a histologic and molecular study. Am J Surg Pathol 2001; 25(4): 508–515.
224. Scieux C, Barnes R, Bianchi A, et al. Lymphogranuloma venereum: 27 cases in Paris. J Infect Dis 1989; 160: 662.
225. Klotz SA, Drutz DJ, Tam MR, et al. Hemorrhagic proctitis due to lymphogranuloma venereum serogroup L2 – diagnosis by fluorescent monoclonal antibody. N Engl J Med 1983; 308: 1563.
226. Maurin M, Raoult D. Bartonella (Rochalimaea) quintana infections. Clin Microbiol Rev 1996; 9: 273.
227. Relman DA, Loutit JS, Schmidt TM, et al. The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens. N Engl J Med 1990; 323: 1573.
228. LeBoit PE, Berger TG, Egbert BM, et al. Bacillary angiomatosis. The histopathology and differential diagnosis of a pseudoneoplastic infection in patients with human immunodeficiency virus disease. Am J Surg Pathol 1989; 13: 909.
229. Oddo D, Casanova M, Acuna G, et al. Acute Chagas’ disease (Trypanosomiasis americana) in acquired immunodeficiency syndrome: report of two cases. Hum Pathol 1992; 23: 41.
230. Pinals RS. Fever, eosinophilia, and periorbital edema. Hosp Pract (Off Ed) 1988; 23: 55–74.
231. Beckman EN, Leonard GL, Castillo LE, et al. Histopathology of marine vibrio wound infections. Am J Clin Pathol 1981; 76: 765.
232. Woo ML, Patrick WG, Simon MT, et al. Necrotising fasciitis caused by Vibrio vulnificus. J Clin Pathol 1984; 37: 1301.
233. Tacket CO, Barrett TJ, Mann JM, et al. Wound infections caused by Vibrio vulnificus, a marine vibrio, in inland areas of the United States. J Clin Microbiol 1984; 19: 197.
234. Joseph SW, Daily OP, Hunt WS, et al. Aeromonas primary wound infection of a diver in polluted waters. J Clin Microbiol 1979; 10: 46.
235. Pfischner WCE, Tshak KG, Neptune EM. Brucellosis in Egypt. A review of experience with 228 patients. Am J Med 1957; 22: 915.
236. Buchanan TM, Faber LC, Feldman RA. Brucellosis in the United States 1960–1972. An abattoir-associated disease. Part 1. Clinical features and therapy. Medicine (Baltimore) 1974; 53: 403.
237. Hunt AC, Bothwell PW. Histological findings in human brucellosis. J Clin Pathol 1967; 20: 267.
238. Simpson WM. Undulant fever (brucellosis) – a clinicopathologic study of ninety cases occurring in and about Dayton, Ohio. Ann Intern Med 1930; 4: 238.
239. Spink WW, Hoffbauer FW, Walker WW, et al. Histopathology of the liver in human brucellosis. J Lab Clin Med 1949; 34: 40.
240. Fend F, Prior C, Margreiter R, et al. Cytomegalovirus pneumonitis in heart–lung transplant recipients: histopathology and clinicopathologic considerations. Hum Pathol 1990; 21: 918.
241. Craighead JE. Cytomegalovirus pulmonary disease. Pathobiol Ann 1975; 5: 197.
242. Myers JD, Spencer HCJ, Watts JC, et al. Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med 1975; 82: 181.
243. Heurlin N, Brattstrom C, Tyden G, et al. Cytomegalovirus the predominant cause of pneumonia in renal transplant patients. A two-year study of pneumonia in renal transplant recipients with evaluation of fiberoptic bronchoscopy. Scand J Infect Dis 1989; 21: 245.
244. Beschorner WE, Hutchins GM, Burns WH, et al. Cytomegalovirus pneumonia in bone marrow transplant recipients: miliary and diffuse patterns. Am Rev Respir Dis 1980; 122: 107.
245. Adams EB, MacLeod IN. Invasive amebiasis–amebic dysentery and its complications. Medicine (Baltimore) 1977; 56: 315–324.
246. Adams EB, MacLeod IN. Invasive amebiasis–amebic liver abscess and its complications. Medicine (Baltimore) 1977; 56: 325–334.
247. Sorvillo FJ, Strassburg MA, Seidel J, et al. Amebic infections in asymptomatic homosexual men, lack of evidence of invasive disease. Am J Publ Health 1986; 76: 1137.
248. Diamond LS, Clark CG. A redescription of Entamoeba histolytica (Schaudinn, 1903; emended Walker, 1911) separating it from Entamoeba dispar (Brumpt, 1925). J Euk Microbiol 1993; 40: 340.
249. Cohen C, Trapuckd S. Toxoplasma cyst with toxoplasmic lymphadenitis. Hum Pathol 1984; 15: 396.
250. Weiss LM, Chen YY, Berry GJ, et al. Infrequent detection of Toxoplasma gondii genome in toxoplasmic lymphadenitis: a polymerase chain reaction study. Hum Pathol 1992; 23: 154.
251. Oksenhendler E, Cadranel J, Sarfati C, et al. Toxoplasma gondii pneumonia in patients with the acquired immunodeficiency syndrome. Am J Med 1990; 88: 5–18N.
252. Falangola MF, Reichler BS, Petito CK. Histopathology of cerebral toxoplasmosis in human immunodeficiency virus infection: a comparison between patients with early-onset and late-onset acquired immunodeficiency syndrome. Hum Pathol 1994; 25: 1091.
253. Nash G, Kerschmann RL, Herndier B, et al. The pathological manifestations of pulmonary toxoplasmosis in the acquired immunodeficiency syndrome. Hum Pathol 1994; 25: 652.
254. Kaye D. The spectrum of Strongyloidiasis. Hosp Pract (Off Ed) 1988; 23: 111–126.
255. Shandera WX, White AC Jr, Chen JC. Neurocysticercosis in Houston, Texas: a report of 112 cases. Medicine (Baltimore) 1994; 73: 37.
256. King CH. Acute and chronic schistosomiasis. Hosp Pract (Off Ed) 1991; 26: 117–130.
257. Smith JH, Christie JD. The pathobiology of Schistosoma haematobium infection in humans. Hum Pathol 1986; 17: 333.
258. Ma P, Visvesvara GS, Martinez AJ, et al. Naegleria and Acanthamoeba infections: a review. Rev Infect Dis 1990; 12: 490.
259. Tan B, Weldon-Linne CM, Rhone DP, et al. Acanthamoeba infection presenting as skin lesions in patients with the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1993; 117: 1043.
260. Visvesvara GS, Martinez AJ, Schuster FL, et al. Leptomyxid ameba: a new agent of amebic meningoencephalitis in humans and animals. J Clin Microbiol 1990; 28: 2750.
261. Deol I, Robledo L, Meza A, et al. Encephalitis due to a free-living amoeba (Balamuthia mandrillaris): case report with literature review. Surg Neurol 2000; 53(6): 611–616.
262. Falkow S. Molecular Koch’s postulates applied to microbial pathogenicity. Rev Infect Dis 1988; 10: S274.
263. Enns RK and the NCCLS Subcommittee on Molecular Microbiology. Molecular diagnostic methods for infectious diseases: proposed guideline. NCCLS medical microbiology – proposed standard, 3-P, vol. 14, No. 4, 1994.
264. Chen SC, Kontoyiannis DP. New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients. Curr Opin Infect Dis 2010; 23: 567–577.
265. Bravo LT, Procop GW. Recent advances in diagnostic microbiology. Semin Hematol 2009; 46; 248–258.
266. Gupta E, Bhalla P, Khurana N, Singh T. Histopathology for the diagnosis of infectious disease. Indian J Med Microbiol 2009; 27; 100–106.
267. Braun-Falco M, Schempp W, Weyers W. Molecular diagnosis in dermatopathology: what makes sense and what doesn’t. Exp Dermatol 2009; 18; 12–23.
268. Gulley ML, Tang W. Laboratory tests for Epstein–Barr virus-related disease. J Mol Diagn 2008; 10: 279–292.
269. Iwasaki T. Contribution of experimental paradigms of viral infectious diseases to diagnostic pathology. Semin Diagn Pathol 2007; 24: 237–242.
270. Mothershed EA, Whitney AM. Nucleic acid-based methods for the detection of bacterial pathogens: present and future considerations for the clinical laboratory. Clin Chim Acta 2006; 363: 206–220.
271. Sra KK, Torres G, Rady P, Hughes TK, Payne DA, Tyring SK. Molecular diagnosis of infectious disease in dermatology. J Am Acad Dermatol 2005; 53; 749–765.
272. Sellon RK. Update on molecular techniques for diagnostic testing of infectious disease. Vet Clin North Am Small Anim Pract 2003; 33: 677–693.